Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Maria S Manola

11PUBLICATIONS

26CO-AUTHORS

Artificial life and complex adaptive systemsPlant and fungus systematics and taxonomyGenomics and transcriptomicsAgricultural molecular engineering of nucleic acids and proteinsPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Nov 24, 2023

Sustained Nrf2 Overexpression-Induced Metabolic Deregulation Can Be Attenuated by Modulating Insulin/Insulin-like Growth Factor Signaling.

Sentiljana Gumeni, Maria Lamprou, Zoi Evangelakou

|Jun 20, 2022

Isolation of an Extract from the Soft Coral Symbiotic Microorganism <i>Salinispora arenicola</i> Exerting Cytoprotective and Anti-Aging Effects.

Xanthippi P Louka, Aimilia D Sklirou, Géraldine Le Goff

|Feb 25, 2022

Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222.

Evangelos Terpos, Vangelis Karalis, Ioannis Ntanasis-Stathopoulos

|Feb 25, 2022

Predictive Factors for Neutralizing Antibody Levels Nine Months after Full Vaccination with BNT162b2: Results of a Machine Learning Analysis.

Dimitris Papadopoulos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou

|Dec 24, 2021

Differential Dose- and Tissue-Dependent Effects of foxo on Aging, Metabolic and Proteostatic Pathways.

Maria S Manola, Sentiljana Gumeni, Ioannis P Trougakos

|Nov 15, 2021

Kinetics of anti-SARS-CoV-2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.

Efstathios Kastritis, Evangelos Terpos, Zoi Evangelakou

Pageof 2

Frequent Collaborators

10 joint publications

Ioannis P Trougakos

5 joint publications

Evangelos Terpos

5 joint publications

Meletios-Athanasios Dimopoulos

3 joint publications

Despoina D Gianniou

3 joint publications

Eleni-Dimitra Papanagnou

3 joint publications

Aimilia D Sklirou

2 joint publications

Ourania E Tsitsilonis

2 joint publications

Dimitrios Paraskevis

2 joint publications

Nikolaos Thomaidis

2 joint publications

Evangelia-Georgia Kostaki

Frequent Collaborators

10 joint publications

Ioannis P Trougakos

5 joint publications

Evangelos Terpos

5 joint publications

Meletios-Athanasios Dimopoulos

3 joint publications

Despoina D Gianniou

Top Related Videos

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on : May 04, 2021

Fluorescence-Activated Cell Sorting for the Isolation of Scleractinian Cell Populations

Fluorescence-Activated Cell Sorting for the Isolation of Scleractinian Cell Populations

Published on : May 31, 2020

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

See more related videos

Top Related Videos

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on : May 04, 2021

Fluorescence-Activated Cell Sorting for the Isolation of Scleractinian Cell Populations

Fluorescence-Activated Cell Sorting for the Isolation of Scleractinian Cell Populations

Published on : May 31, 2020

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

See more related videos